Physician profile
Jonathan M Gilbert
NPI 1093735128
$4,101.99
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $505 · 2020: $149 · 2021: $581 · 2022: $936 · 2023: $1,159 · 2024: $772.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,481 · Consulting Fee: $450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,480.78 |
| Consulting Fee | $450.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $877.05 | 2021-2024 | Linq II, Selectsecure |
| Novo Nordisk INC | $535.87 | 2022-2024 | Rybelsus, Ozempic, Wegovy |
| E.R. Squibb & Sons, L.L.C. | $474.80 | 2019-2024 | Camzyos, Cobenfy |
| Novartis Pharmaceuticals Corporation | $397.03 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $319.36 | 2019-2023 | Jardiance |
| Baxter Healthcare | $315.00 | 2022 | |
| Janssen Pharmaceuticals, INC | $212.81 | 2019-2023 | Opsumit, Xarelto |
| Pfizer INC. | $197.69 | 2019-2024 | |
| Impulse Dynamics (USA) INC. | $175.94 | 2023 | Optimizer |
| Edwards Lifesciences Corporation | $161.65 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $135.86 | 2019-2023 | Brilinta |
| Amgen INC. | $121.39 | 2019-2024 | Repatha |
| Abbott Laboratories | $60.32 | 2023 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Kiniksa Pharmaceuticals, LTD. | $45.41 | 2023 | Arcalyst |
| Abiomed | $30.31 | 2024 | Impella |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $28.37 | 2019-2020 | |
| Lilly USA, LLC | $13.13 | 2023 | Mounjaro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Gilbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.